cbdMD (YCBD) 10-K 15 Dec 22 2022 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Sep. 30, 2022	Dec. 09, 2022	Mar. 31, 2022
Document Information [Line Items]
Entity Central Index Key	0001644903
Entity Registrant Name	cbdMD, Inc.
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Document Type	10-K
Document Annual Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-38299
Entity Incorporation, State or Country Code	NC
Entity Tax Identification Number	47-3414576
Entity Address, Address Line One	8845 Red Oak Blvd
Entity Address, City or Town	Charlotte
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28217
City Area Code	704
Local Phone Number	445-3060
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 42,426,087
Entity Common Stock, Shares Outstanding		60,682,262
Auditor Name	Cherry Bekaert LLP
Auditor Firm ID	677
Auditor Location	Charlotte, North Carolina
Series A Cumulative Convertible Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	8% Series A Cumulative Convertible Preferred Stock
Trading Symbol	YCBDpA
Security Exchange Name	NYSEAMER
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	common
Trading Symbol	YCBD
Security Exchange Name	NYSEAMER

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Sep. 30, 2021
Current assets:
Cash and cash equivalents	$ 6,720,234	$ 26,411,424
Accounts receivable	1,447,831	1,113,372
Accounts receivable – discontinued operations	1,375	10,967
Marketable securities, at cost	0	33,351
Investment other securities	1,000,000	1,000,000
Inventory	4,255,914	5,021,867
Inventory prepaid	511,459	551,519
Prepaid sponsorship	1,372,845	1,212,682
Prepaid expenses and other current assets	701,945	1,147,178
Total current assets	16,011,603	36,502,360
Other assets:
Property and equipment, net	823,310	2,561,574
Operating lease assets	4,477,841	5,614,960
Deposits for facilities	244,606	529,583
Intangible assets	17,834,549	23,003,929
Goodwill	0	56,670,970
Investment in other securities, noncurrent	1,400,000	0
Total other assets	24,780,306	88,381,016
Total assets	40,791,909	124,883,376
Current liabilities:
Accounts payable	2,036,558	2,978,914
Accrued expenses	2,060,762	2,727,612
Operating leases – current portion	1,178,683	1,151,150
Note payable	9,609	59,470
Total current liabilities	5,285,612	6,917,146
Long term liabilities:
Long term liabilities	125,491	108,985
Operating leases - long term portion	3,680,375	4,859,058
Contingent liability	276,000	9,856,000
Total long term liabilities	4,081,866	14,824,043
Total liabilities	9,367,478	21,741,189
Commitments and Contingencies (Note 11)
cbdMD, Inc. shareholders' equity:
Preferred stock, authorized 50,000,000 shares, $0.001 par value, 5,000,000 and 500,000 shares issued and outstanding, respectively	5,000	5,000
Common stock, authorized 150,000,000 shares, $0.001 par value, $60,665,595 and 57,783,340 shares issued and outstanding, respectively	60,666	57,783
Additional paid in capital	178,782,328	176,417,269
Accumulated deficit	(147,423,563)	(73,337,865)
Total cbdMD, Inc. shareholders' equity	31,424,431	103,142,187
Total liabilities and shareholders' equity	$ 40,791,909	$ 124,883,376

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2022	Sep. 30, 2021	Jul. 22, 2021
Preferred Stock, Shares Authorized (in shares)	50,000,000	50,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.001	$ 0.001
Preferred Stock, Shares Issued (in shares)	5,000,000	5,000,000
Preferred Stock, Shares Outstanding, Ending Balance (in shares)	500,000	500,000
Common Stock, Shares Authorized (in shares)	150,000,000	150,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares, Issued (in shares)	60,665,595	57,783,340	300,000
Common Stock, Shares, Outstanding, Ending Balance (in shares)	60,665,595	57,783,340

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Gross Sales	$ 37,122,215	$ 47,332,085
Allowances	(1,718,991)	(2,851,322)
Total Net Sales	35,403,224	44,480,763
Cost of sales	13,066,639	14,495,063
Gross Profit	22,336,585	29,985,700
Operating expenses	39,647,130	49,601,690
Impairment of goodwill and other intangible assets	60,955,970	0
Loss from operations	(78,266,515)	(19,615,990)
Realized and Unrealized gain (loss) on marketable and other securities, including impairments	(33,350)	546,878
Gain on extinguishment of debt	0	1,466,113
Gain on sale of assets	88,769	0
Restructuring expense	(602,092)	0
Decrease (increase) of contingent liability	8,473,999	(6,687,439)
Other income	239,250	29,479
Interest expense	16,246	(28,930)
Loss before provision for income taxes	(70,083,693)	(24,289,889)
Benefit for income taxes	0	895,000
Net Loss	(70,083,693)	(23,394,889)
Preferred dividends	4,002,005	2,554,609
Net Loss available to cbdMD, Inc. common shareholders	$ (74,085,698)	$ (25,949,498)
Net Loss per share:
Basic earnings per share (in dollars per share)	$ (1.24)	$ (0.47)
Diluted earnings per share (in dollars per share)	$ (1.24)	$ (0.47)
Weighted average number of shares Basic: (in shares)	59,750,301	54,938,128
Weighted average number of shares Diluted: (in shares)	59,750,301	54,938,128

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Net Loss	$ (70,083,693)	$ (23,394,889)
Comprehensive Loss	(70,083,693)	(23,394,889)
Preferred dividends	(4,002,005)	(2,554,609)
Comprehensive Loss available to cbdMD, inc. common shareholders	$ (74,085,698)	$ (25,949,498)

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	3 Months Ended				12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net Loss	$ (14,631,432)	$ (19,160,904)		$ (9,395,621)	$ (70,083,693)	$ (23,394,889)
Adjustments to reconcile net (income) loss to net cash used by operating activities:
Stock based compensation					555,215	1,298,106
Restricted stock expense					373,610	1,626,613
Marketing stock amortization					907,774	871,390
Issuance of stock / warrants for service					0	97,720
Inventory and materials impairment		878,142			878,142	670,580
Intangibles amortization					884,380	0
Depreciation					948,962	1,017,408
Impairment of goodwill and other intangible assets					60,955,970	0
Gain on sale of fixed assets					(322,017)	0
Increase/(Decrease) in contingent liability					(8,473,999)	6,687,439
Realized and unrealized loss (gain) of Marketable and other securities					33,350	(546,878)
Termination benefit					0	196,896
Extinguishment of Paycheck Protection Program Loan					0	(1,466,113)
Amortization of operating lease asset					1,137,119	1,236,397
Changes in operating assets and liabilities:
Accounts receivable					65,541	(183,735)
Deposits					284,977	261,125
Inventory					(112,189)	(1,009,192)
Prepaid inventory					40,060	(263,341)
Prepaid expenses and other current assets					(289,586)	525,670
Accounts payable and accrued expenses					(1,812,547)	(104,422)
Operating lease liability					(1,151,152)	(1,159,097)
Deferred revenue / customer deposits					203,341	3,723
Collection on discontinued operations accounts receivable					9,592	436,167
Deferred tax liability					0	(895,000)
Cash used by operating activities					(14,967,150)	(14,093,433)
Cash flows from investing activities:
Proceeds from sale of other investment securities					0	540,000
Purchase of other investment securities					0	(750,000)
Purchase of DirectCBDOnline.com					0	(2,000,000)
Purchase of property and equipment					(688,680)	(342,013)
Cash provided (used) by investing activities					(688,680)	(2,552,013)
Cash flows from financing activities:
Proceeds from issuance of common stock					0	0
Proceeds from issuance of preferred stock					0	30,938,386
Note payable					(33,355)	(151,551)
Preferred dividend distribution					(4,002,005)	(2,554,609)
Deferred Issuance costs					0	0
Cash provided by financing activities					(4,035,360)	28,232,226
Net increase (decrease) in cash					(19,691,190)	11,586,780
Cash and cash equivalents, beginning of period		$ 26,411,424		$ 14,824,644	26,411,424	14,824,644
Cash and cash equivalents, end of period	$ 6,720,234		$ 26,411,424		$ 6,720,234	26,411,424	$ 14,824,644
Interest expense						2,364	33,693
Warrants to Purchase Common Stock [Member] | Representative of the Underwriters [Member]
Non-cash financial/investing activities:
Warrants issued to representative						0	524,113
Common Stock Earnout Shares [Member]
Non-cash financial/investing activities:
Issuance of Contingent earnout shares:						$ 1,086,000	$ 4,620,000

Consolidated Statements of Shar

Consolidated Statements of Shareholders' (Deficit) Equity - USD ($)	Share-Based Payment Arrangement, Option [Member] Common Stock [Member]	Share-Based Payment Arrangement, Option [Member] Preferred Stock [Member]	Share-Based Payment Arrangement, Option [Member] Additional Paid-in Capital [Member]	Share-Based Payment Arrangement, Option [Member] Retained Earnings [Member]	Share-Based Payment Arrangement, Option [Member]	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Sep. 30, 2020						52,130,870	500,000
Balance at Sep. 30, 2020						$ 52,131	$ 500	$ 126,517,784	$ (47,388,367)	$ 79,182,048
Issuance of stock (in shares)						0	2,300,000
Issuance of stock						$ 0	$ 2,300	15,795,815	0	15,798,115
Issuance of options for share based compensation						0	0	219,875	0	219,875
Issuance of restricted stock for share based compensation						0	0	15,279	0	15,279
Preferred dividend						0	0	0	(100,050)	(100,050)
Net Loss						0	0	0	(9,395,621)	(9,395,621)
Issuance of options for share based compensation, net						0	0	(219,875)	0	(219,875)
Issuance of stock costs						$ 0	$ 0	0	0	0
Balance (in shares) at Dec. 31, 2020						52,130,870	2,800,000
Balance at Dec. 31, 2020						$ 52,131	$ 2,800	142,548,753	(56,884,038)	85,719,646
Balance (in shares) at Sep. 30, 2020						52,130,870	500,000
Balance at Sep. 30, 2020						$ 52,131	$ 500	126,517,784	(47,388,367)	79,182,048
Net Loss										$ (23,394,889)
Issuance of options for share based compensation (in shares)										147,953
Balance (in shares) at Sep. 30, 2021						57,783,340	5,000,000
Balance at Sep. 30, 2021						$ 57,783	$ 5,000	176,417,269	(73,337,865)	$ 103,142,187
Balance (in shares) at Dec. 31, 2020						52,130,870	2,800,000
Balance at Dec. 31, 2020						$ 52,131	$ 2,800	142,548,753	(56,884,038)	85,719,646
Issuance of stock (in shares)						3,711,964	0
Issuance of stock						$ 3,712	$ 0	11,422,488	0	11,426,200
Issuance of options for share based compensation						148	0	627,500	0	627,648
Issuance of restricted stock for share based compensation						347	0	1,181,481	0	1,181,828
Preferred dividend						0	0	0	(560,279)	(560,279)
Net Loss						0	0	0	(12,510,474)	(12,510,474)
Issuance of options for share based compensation, net						$ (148)	$ 0	(627,500)	0	(627,648)
Issuance of options for share based compensation (in shares)						147,953	0
Issuance of restricted stock for share based compensation (in shares)						347,000	0
Balance (in shares) at Mar. 31, 2021						56,337,787	2,800,000
Balance at Mar. 31, 2021						$ 56,338	$ 2,800	155,780,222	(69,954,791)	85,884,569
Issuance of stock (in shares)						608,528	0
Issuance of stock						$ 609	$ 0	1,471,991	0	1,472,600
Issuance of options for share based compensation						0	0	355,565	0	355,565
Issuance of restricted stock for share based compensation						28	0	590,264	0	590,292
Preferred dividend						0	0	0	(560,281)	(560,281)
Net Loss						0	0	0	1,537,288	1,537,288
Issuance of options for share based compensation, net						$ 0	$ 0	(355,565)	0	(355,565)
Issuance of restricted stock for share based compensation (in shares)						27,500	0
Balance (in shares) at Jun. 30, 2021						56,973,815	2,800,000
Balance at Jun. 30, 2021						$ 56,975	$ 2,800	158,198,042	(68,977,784)	89,280,033
Issuance of options for share based compensation						0	0	493,000	0	493,000
Issuance of restricted stock for share based compensation						0	0	479,899	0	479,899
Preferred dividend						0	0	0	(1,333,999)	(1,333,999)
Net Loss									(3,026,082)
Issuance of options for share based compensation, net						$ 0	$ 0	(493,000)	0	(493,000)
Issuance of Common stock (in shares)						809,525	0
Issuance of Common stock						$ 809	$ 0	919,491	0	0
Issuance of Preferred Stock (in shares)						0	2,200,000
Issuance of Preferred Stock						$ 0	$ 2,200	15,142,571	0	15,144,771
Acquisition of DCO						$ 0	$ 0	1,184,265	0	1,184,265
Balance (in shares) at Sep. 30, 2021						57,783,340	5,000,000
Balance at Sep. 30, 2021						$ 57,783	$ 5,000	176,417,269	(73,337,865)	103,142,187
Issuance of stock (in shares)						494,630	0
Issuance of stock						$ 495	$ 0	404,505	0	405,000
Issuance of options for share based compensation	$ 0	$ 0	$ 505,466	$ 0	$ 505,466
Issuance of restricted stock for share based compensation						0	0	508,754	0	508,754
Preferred dividend						0	0	0	(1,000,502)	(1,000,502)
Net Loss						$ 0	$ 0	0	(19,160,904)	(19,160,904)
Issuance of options for share based compensation, net	0	0	(505,466)	0	(505,466)
Balance (in shares) at Dec. 31, 2021						58,277,970	5,000,000
Balance at Dec. 31, 2021						$ 58,278	$ 5,000	177,835,993	(93,499,271)	84,400,000
Balance (in shares) at Sep. 30, 2021						57,783,340	5,000,000
Balance at Sep. 30, 2021						$ 57,783	$ 5,000	176,417,269	(73,337,865)	103,142,187
Net Loss										$ (70,083,693)
Issuance of options for share based compensation (in shares)										0
Balance (in shares) at Sep. 30, 2022						60,665,595	5,000,000
Balance at Sep. 30, 2022						$ 60,666	$ 5,000	178,782,328	(147,423,563)	$ 31,424,431
Balance (in shares) at Dec. 31, 2021						58,277,970	5,000,000
Balance at Dec. 31, 2021						$ 58,278	$ 5,000	177,835,993	(93,499,271)	84,400,000
Issuance of stock (in shares)						1,074,240	0
Issuance of stock						$ 1,074	$ 0	659,926	0	661,000
Issuance of options for share based compensation	0	0	291,630	0	291,630
Issuance of restricted stock for share based compensation						0	0	328,514	0	328,514
Preferred dividend						0	0	0	(1,000,500)	(1,000,500)
Net Loss						$ 0	$ 0	0	(4,657,215)	(4,657,215)
Issuance of options for share based compensation, net	$ 0	$ 0	$ (291,630)	$ 0	$ (291,630)
Balance (in shares) at Mar. 31, 2022						59,352,210	5,000,000
Balance at Mar. 31, 2022						$ 59,352	$ 5,000	179,116,063	(99,156,986)	80,023,429
Issuance of stock (in shares)						593,880	0
Issuance of stock						$ 594	$ 0	177,406	0	178,000
Issuance of options for share based compensation						0	0	(373,168)	0	(373,168)
Issuance of restricted stock for share based compensation						0	0	(593,617)	0	(593,617)
Preferred dividend						0	0	0	(1,000,501)	(1,000,501)
Net Loss						0	0	0	(31,634,143)	(31,634,143)
Issuance of options for share based compensation, net						$ 0	$ 0	373,168	0	373,168
Balance (in shares) at Jun. 30, 2022						59,946,090	5,000,000
Balance at Jun. 30, 2022						$ 59,946	$ 5,000	178,326,684	(131,791,630)	46,600,000
Issuance of stock (in shares)						719,505	0
Issuance of stock						$ 720	$ 0	197,281	0	198,000
Issuance of options for share based compensation						0	0	128,404	0	128,404
Issuance of restricted stock for share based compensation						0	0	129,959	0	129,960
Preferred dividend						0	0	0	(1,000,501)	(1,000,501)
Net Loss						0	0	0	(14,631,432)	(14,631,432)
Issuance of options for share based compensation, net						$ 0	$ 0	(128,404)	0	(128,404)
Balance (in shares) at Sep. 30, 2022						60,665,595	5,000,000
Balance at Sep. 30, 2022						$ 60,666	$ 5,000	$ 178,782,328	$ (147,423,563)	$ 31,424,431

Note 1 - Organization and Summa

Note 1 - Organization and Summary of Significant Accounting Policies	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 1 ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization and Nature of Business cbdMD, Inc. ("cbdMD", "we", "us", “our”, or the “Company”) is a North Carolina corporation formed on March 17, 2015 November 2016 May 1, 2019 September 30. On December 20, 2018 ( two April 2019, five 2,187,500 September 30, 2022, five September 30,2022. The Company owns and operates the nationally recognized CBD (cannabidiol) brands cbdMD, Paw CBD and cbdMD Botanicals. The Company sources cannabinoids, including CBD, which are extracted from non-GMO hemp grown on farms in the United States. CBD and other hemp-derived cannabinoids are natural substances produced from the hemp plant. The products manufactured by and for the Company comply with the 2018 0.3% 2018 not In the third 2019 October 22, 2019, March 15, 2021 The consolidated financial statements of cbdMD have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report filed with the SEC on Form 10 September 30, 2022 2022 10 December 15, 2022. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries CBDI, Paw CBD and Therapeutics. All material intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are not On March 11, 2020, 19 19 Cash and Cash Equivalents For financial statements purposes, the Company considers all highly liquid investments with a maturity of less than three Accounts Receivable and Accounts Receivable Other Accounts receivables are stated at cost less an allowance for doubtful accounts, if applicable. Credit is extended to customers after an evaluation of the customer’s financial condition, and generally collateral is not September 30, 2022 September 30, 2021, Merchant Receivable The Company primarily sells its products through the internet and has an arrangement to process customer payments with multiple third 2 5 September 30, 2022, Inventory Inventory is stated at the lower of cost or net realizable value with cost being determined on a weighted average basis. The cost of inventory includes product cost, freight-in, and production fill and labor (portions of which we outsource to third Customer Deposits Customer deposits consist of payments received in advance of revenue recognition. Revenue is recognized as revenue recognition criteria are met. Property and Equipment Property and equipment items are stated at cost less accumulated depreciation. Expenditures for routine maintenance and repairs are charged to operations as incurred. Depreciation is charged to expense over the estimated useful lives of the assets using the straight-line method. Generally, the useful lives are five three may not Fair Value Accounting The Company utilizes accounting standards for fair value, which include the definition of fair value, the framework for measuring fair value, and disclosures about fair value measurements. Fair value is a market-based measurement, not 1 2 3 Level 1 2 1 2 may 3 When the Company records an investment in marketable securities the carrying value is recorded at fair value. Any changes in fair value for marketable securities during a given period will be recorded as an unrealized gain or loss in the consolidated statement of operations. For investment other securities without a readily determinable fair value, the Company may Goodwill Goodwill represents the excess of cost of an acquired business over the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed in a business combination. Identifiable intangible assets acquired in business combinations are recorded based on their fair values at the date of acquisition. Goodwill is not not In performing a goodwill test, the Company performs a qualitative evaluation and if necessary, a quantitative evaluation. Factors considered in the qualitative test include specific operating results as well as new events and circumstances impacting the operations or cash flows of the business acquired. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of the business to the respective fair value. The Company determines the fair value of its acquired business using a combination of income-based and market-based approaches and incorporates assumptions it believes market participants would utilize. The income-based approach utilizes discounted cash flows while the market-based approach utilizes market capitalization comparisons. These approaches are dependent upon internally developed forecasts that are based upon annual budgets and longer-range strategic plans. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective acquired business and in the internally developed forecasts. The Company has analyzed a variety of factors on its business to determine if a circumstance could trigger an impairment loss. See Note 5 Intangible Assets The Company's intangible assets consist of trademarks and other intellectual property, all of which were previously accounted for in accordance with Accounting Standards Codification (ASC) Topic 350, Intangibles Goodwill and Other not August 1 350 30 35 18. not not 5 December 31, 2021 360, 20 January 1, 2022 360, may not may not two 360, 360, Contingent Liability A significant component of the purchase price consideration for the Company’s acquisition of Cure Based Development includes a fixed number of future shares to be issued as well as a variable number of future shares to be issued based upon the post-acquisition entity reaching certain specified future revenue targets, as further described in Note 6. Paycheck Protection Program Loan On April 27, 2020, May 17, 2021 Revenue Recognition Under ASC 606, Revenue from Contracts with Customers, five 606: Performance Obligations A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company meets that obligation when it has shipped products which have been ordered by the customer. The Company has reviewed its various revenue streams for its other contracts under the five Allocation of Transaction Price In the Company’s current business model, it does not Revenue Recognition The Company records revenue from the sale of its products when risk of loss and title to the product are transferred to the customer, which is upon shipping (and is typically FOB shipping) which is when our performance obligation is met. Net sales are comprised of gross revenues less product returns, trade discounts and customer allowances, which include costs associated with off-invoice mark-downs and other price reductions, as well as trade promotions. These incentive costs are recognized at the later of the date on which the Company recognizes the related revenue or the date on which the Company offers the incentive. The Company currently offers a 60 Disaggregated Revenue The Company’s product revenue is generated primarily through two A description of the Company’s principal revenue generating activities are as follows: - E-commerce sales - consumer products sold through the Company’s online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due prior to the date of shipment; and - Wholesale sales - products sold to the Company’s wholesale customers for subsequent resale. Revenue is recognized when control of the goods is transferred to the customer, in accordance with the terms of the applicable agreement. Payment terms vary and can typically be 30 The following table represents a disaggregation of revenue by sales channel: Fiscal 2022 % of total Fiscal 2021 % of total E-commerce sales $ 26,435,203 74.7 % $ 32,907,956 74.0 % Wholesale sales 8,968,021 25.3 % 11,572,807 26.0 % Total Net Sales $ 35,403,224 $ 44,480,763 Contract assets represent unbilled receivables and are presented within accounts receivable, net on the consolidated balance sheets. Contract liabilities represent unearned revenues and are presented as deferred revenue or customer deposits on the consolidated balance sheets. The Company has no September 30, 2022 Cost of Sales The Company’s cost of sales includes costs associated with distribution, fill and labor expense, components, manufacturing overhead, third Advertising Costs The Company expenses all costs of advertising and related marketing and promotional costs as incurred. The Company incurred $14,332,235 and $15,835,139 in advertising and marketing and promotional costs included in operating expenses during the years ended September 30, 2022 2021 Income Taxes The Company is a North Carolina corporation that is treated as a corporation for federal and state income tax purposes. As of October 1, 2019, March 15, 2021, The Company accounts for income taxes pursuant to the provisions of the Accounting for Income Taxes 740 not not US GAAP requires management to evaluate tax positions taken by the Company and recognize a tax liability (or asset) if the Company has taken an uncertain tax position that more likely than not not September 30, 2022 2021 no Concentrations Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities. The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (“FDIC”) covers $250,000 for substantially all depository accounts. The Company from time to time may September 30, 2022 September 30, 2021 Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did not September 30, 2022 Stock-Based Compensation The Company accounts for its stock compensation under the ASC 718 10 30, Compensation - Stock Compensation may The Company uses the Black-Scholes model for measuring the fair value of options and warrants. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. The Company recognizes forfeitures when they occur. Liquidity and Going Concern Considerations The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company experienced a loss of $74,086,731 for the fiscal year ended September 30, 2022. one While the Company is taking strong action, believes in the viability of its strategy and path to profitability, and in its ability to raise additional funds, there can be no may not twelve twelve not may not Restructuring The Company recorded a one September 30, 2022. Earnings (Loss) Per Share The Company uses ASC 260 10, Earnings Per Share Recently Adopted Accounting Standards In December 2019, 2019 12, 740 740 not not 2019 12 December 15, 2020, no

Note 2 - Marketable Securities

Note 2 - Marketable Securities and Investment Other Securities	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	NOTE 2 MARKETABLE SECURITIES AND INVESTMENT OTHER SECURITIES The Company has, from time to time, entered into contracts where a portion of the consideration provided by the customer in exchange for the Company's services was common stock, options or warrants (an equity position). In these situations, upon invoicing the customer for the stock or other instruments, the Company recorded the receivable as accounts receivable other, and used the value of the stock or other instrument upon invoicing to determine the value. If there is insufficient data to support the valuation of the security directly, the Company will value it, and the underlying revenue, on the estimated fair value of the services provided. In determining fair value of marketable securities and investment other securities, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and consider counterparty credit risk in our assessment of fair value. The Company determines the fair value of marketable securities and investment other securities based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one ● Level 1 ● Level 2 1 ● Level 3 not Where an accounts receivable other is settled with the receipt of the common stock or other instrument, the common stock or other instrument was classified as an asset on the consolidated balance sheet as either an investment marketable security (when the customer is a public entity) or as an investment other security (when the customer is a privately held entity). For the year ended September 30, 2022 September 30, 2021 2021 zero 19 In September 2020, January 13, 2021, second February 9, 2021, March 24, 2021, June 22, 2022, June 23, 2022, no not not February Adara’s focus of targets to pursue for the business combination are expected to be in the consumer products industry including business in the health and wellness, ecommerce, discretionary spending, information technology sectors and related channels of distribution. On April 7, 2022, The table below summarizes the assets valued at fair value as of September 30, 2022 In Active Markets for Significant Other Identical Assets Observable Total Fair Value and Liabilities Inputs at September 30, (Level 1) (Level 2) 2022 Balance at September 30, 2020 $ 26,472 $ - $ 26,472 Change in value of equities 6,879 - 6,879 Additional Investment - - - Balance at September 30, 2021 33,351 - 33,351 Change in value of equities (33,351 ) (33,351 ) Additional Investment - - Balance at September 30, 2022 $ - $ - $ -

Note 3 - Inventory

Note 3 - Inventory	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 3 INVENTORY Inventory at September 30, 2022 2021 Septmeber 30 September 30, 2022 2021 Finished Goods $ 3,198,488 $ 3,362,897 Inventory Components 1,213,724 1,729,176 Inventory Reserve (156,298 ) (70,206 ) Inventory prepaid 511,459 551,519 Total Inventory $ 4,767,373 $ 5,573,386 Abnormal amounts of idle facility expense, freight, handling costs, scrap, and wasted material (spoilage) are expensed in the period they are incurred and no September 30, 2022 first September 30, 2022

Note 4 - Property and Equipment

Note 4 - Property and Equipment	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4 PROPERTY AND EQUIPMENT Major classes of property and equipment at September 30, 2022 2021 September 30, September 30, 2022 2021 Computers, furniture and equipment $ 1,095,228 $ 549,910 Manufacturing equipment 284,275 2,968,838 Leasehold improvements 487,081 870,621 Automobiles 11,087 35,979 1,877,671 4,425,348 Less accumulated depreciation (1,054,361 ) (1,863,774 ) Property and equipment, net $ 823,310 $ 2,561,574 Depreciation expense related to property and equipment was $948,962 and $1,017,408 for the year ended September 30, 2022 2021 third

Note 5 - Goodwill and Intangibl

Note 5 - Goodwill and Intangible Assets	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	NOTE 5 GOODWILL AND INTANGIBLE ASSETS Goodwill The Company had goodwill at September 30, 2021 0 350 20 35 3C. three December 31, 2021, 0 350 20 35 3C, December 31, 2021. June 30, 2022 June 30, 2022. September 30, 2022 0 September 30, 2022, Intangible Assets On December 20, 2018, not In September 2019, not In July 2021, As of December 31, 2021, 350 30 35 17, December 31, 2021, 350 January 2022. September 30, 2022 At September 30, 2022, 360 no Intangible assets as of September 30, 2022 2021 September 30, September 30, 2022 2021 Trademark related to cbdMD $ 21,585,000 $ 21,585,000 Trademark for HempMD 50,000 50,000 Technology Relief from Royalty related to DirectCBDOnline.com 667,844 667,844 Tradename related to DirectCBDOnline.com 749,567 749,567 Impairment of definite lived intanigble assets: (4,285,000 ) - Amortization of definite lived intangible assets: (932,862 ) (48,482 ) Total $ 17,834,549 $ 23,003,929 Future amortization of intangible assets as of September 30, 2022 For the year ended September 30, 2023 1,109,418 2024 1,109,418 2025 1,074,634 2026 942,457 2027 942,457 Thereafter 12,656,165 Total future intangibles amortization $ 17,834,549 Goodwill as of September 30, 2022 2021 Goodwill at September 30, 2021 $ 56,670,970 Impairment of goodwill (56,670,970 ) Goodwill at September 30, 2022 $ -

Note 6 - Contingent Liability

Note 6 - Contingent Liability	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Business Combination Disclosure [Text Block]	NOTE 6 CONTINGENT LIABILITY As consideration for the Mergers, described in Note 1, two five The contractual obligations and earn out provision are accounted for as a contingent liability and fair value is determined using Level 3 may The initial two second The Merger Agreement provides that an additional 15,250,000 Earnout Shares would be issued as part of the consideration for the Mergers, upon the satisfaction of certain aggregate net revenue criteria by cbdMD within 60 months following the Closing Date as follows, as measured at four 12, 24, 42, 59 Aggregate Net Revenues Shares Issued/ Each $ of Aggregate Net Revenue Ratio $1 - $20,000,000 .190625 $20,000,001 - $60,000,000 .0953125 $60,000,001 - $140,000,000 .04765625 $140,000,001 - $300,000,000 .23828125 For clarification purposes, the Aggregate Net Revenues during a Marking Period shall be multiplied by the applicable Shares Issued/Each $ of Aggregate Net Revenue Ratio, minus, the number of shares issued as a result of Aggregate Net Revenues during the prior marking periods. The issuance of the initial 15,250,000 shares and the 15,250,000 Earnout Shares were approved by the Company’s shareholders in April 2019. April 19, 2019 third third September 30, 2021 December 2021. fourth third December 31, 2021 March 2022. fifth third March 31, 2022 May 2022. sixth third June 30, 2022 August 2022. September 30, 2022, The third 18 January 1, 2021 June 30, 2022 ( March 31, 2021 No. 1 No. 1” third third six third March 31, 2021, no no No. 1 No. 1 not fourth not September 30, 2022 September 30, 2021 As part of the Twenty Two acquisition in July 2021, one September 30, 2021, December 31, 2021, March 30, 2022 June 30, 2022, September 2022 no In November 2021 twelve December 31, 2022, December 31, 2021 December 31, 2022 zero December 31, 2021. three March 31, 2022, In April 2022, December 2022 not December 2022 September 30, 2022.

Note 7 - Related Party Transact

Note 7 - Related Party Transactions	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 7 RELATED PARTY TRANSACTIONS The Company, as noted in Note 2, 6,

Note 8 - Shareholders' Equity

Note 8 - Shareholders' Equity	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 8 SHAREHOLDERS EQUITY Preferred Stock – The Company is authorized to issue 50,000,000 shares of preferred stock, par value $0.001 per share. In October 2019, 8.0% 8.0% 480 Distinguishing Liabilities from Equity September 30, 2022 September 30, 2021 The total amount of dividends declared and recorded were $4,002,005 and $2,554,609 for the years ended September 30, 2022 2021 Common Stock – The Company is authorized to issue 150,000,000 shares of common stock, par value $0.001 per share. There were 60,665,595 and 57,783,340 shares of common stock issued and outstanding at September 30, 2022 2021 Preferred stock transactions: The Company has no September 30, 2022 In the year ended September 30, 2021 On July 1, 2021, June 30, 2026. Common stock transactions: In the year ended September 30, 2022 In August 2022, In August 2022, In August 2022, 409,505 6. In May 2022, 6. In March 2022 6. In January 2022, six In January 2022, 11. On December 28, 2021, 6. In October 2021, January 1, 2022. In the year ended September 30, 2021 On August 16, 2021 6. In fiscal year ending September 30, 2022 January 2020 On July 22, 2021, On June 8, 2021, On May 14, 2021, 6. On April 9, 2021, In March 2021, July December 2021. In March 2021, one fourth June 30, 2021, one September 30, 2021, one fourth December 31, 2021, one fourth March 31, 2022. In March 2021, 6. In February 2021, In October 2020 one first 9. Stock option transactions: In the year ended September 30, 2022 In August 2022, five In June 2022, In May 2022, 1, 2, 3 five In April 2022, 6 March 2023. five In April 2022, December 2022. September 30, 2022 In March 2022, five 12 In January 2022, 9 three June 30, 2022 In October 2021, October 1, 2022. three twelve September 30, 2022. In the year ended September 30, 2021 In June 2021, 12 In April 2021, three first January 1, 2022, second January 1, 2023 third January 1, 2024, 2021 September 30, 2022 In March 2021, five 12 In January 2021, three three first April 15, 2021, second April 15, 2022 third April 14, 2023 September 30, 2022 In October 2020, three first October 1, 2021, second October 1, 2022 third October 1, 2023, $3.50, 5 September 30, 2022 The expected volatility rate was estimated based on comparison to the volatility of a blend of the Company's own stock and a peer group of companies in similar industries. The expected term used was the full term of the contract for the issuances. The risk-free interest rate for periods within the contractual life of the option is based on U.S. Treasury securities. The pre-vesting forfeiture rate of zero 718, may may The following table summarizes the inputs used for the Black-Scholes pricing model on the options issued in the years ended September 30, 2022 2021 Warrant transactions: The Company has no twelve September 30, 2022. In the year ended September 30, 2021 In July 2021 December 8, 2025. 2022 2021 Weighted average exercise price $ 0.99 $ 3.91 Risk free interest rate 2.56% - 2.97% 0.16% - 0.85% Volatility 101.23% - 103.98% 100.72% Expected term (in years) 2.5 - 5.5 2.5 - 5.5 Divident yield None None In December 2020 December 8, 2025. The following table summarizes the inputs used for the Black-Scholes pricing model on the warrants issued in the year ended September 30, 2022 2021 2022 2021 Weighted average exercise price $ - $3.74 Risk free interest rate 0.00 % 0.39% - 0.89% Volatility 0.00 % 103.42 % Expected term (in years) - 2.75 Divident yield - None

Note 9 - Stock-Based Compensati

Note 9 - Stock-Based Compensation	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	NOTE 9 Equity Compensation Plan – On June 2, 2015, 2015 “2015 2015 2015 first 2015 2016, one September no April 19, 2019, 2015 2015 August 7, 2019 2015 first October 2015 On January 8, 2021, 2021 “2021 March 12, 2021. 2021 2021 2021 2021 October 1 2021 2022, September 30 The Company accounts for stock-based compensation using the provisions of ASC 718. 718 Eligible recipients include employees, officers, directors and consultants who are deemed to have rendered or to be able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the success of the Company. Options granted generally have a five ten one three Stock Options: The Company currently has awards outstanding with service conditions and graded-vesting features. We recognize compensation cost on a straight-line basis over the requisite service period. The fair value of each time-based award is estimated on the date of grant using the Black-Scholes option valuation model. Our weighted-average assumptions used in the Black-Scholes valuation model for equity awards with time-based vesting provisions granted during the year. The following table summarizes stock option activity under both plans for the fiscal years ended September 30, 2022 2021 Weighted-average remaining Aggregate Weighted-average contractual term intrinsic value Number of shares exercise price (in years) (in thousands) Outstanding at September 30, 2020 1,750,000 $ 4.68 $ - Granted 1,380,000 3.91 - Exercised (147,953 ) 2.60 Forfeited (279,547 ) 4.47 Outstanding at September 30, 2021 2,702,500 4.42 5.13 - Granted 1,060,000 0.97 - Exercised - - Forfeited (1,260,000 ) 3.63 Outstanding at September 30, 2022 2,502,500 3.36 4.55 - Exercisable at September 30, 2022 1,549,167 $ 4.13 4.69 $ - As of September 30, 2022 Restricted Stock Award transactions: In the twelve September 30, 2022: In August 2022, In August 2022, In June 2022, one July 1, 2022 January 1, 2023. In May 2022 In May 2022 In March 2022, one fourth June 30, 2022, one September 30, 2022, one fourth December 31, 2022, one fourth March 31, 2023. In January 2022, six In January 2022, 11. In November 2021, December 2022, 6. January 2022. In October 2021 In October 2021 four In the twelve September 30, 2021: In June 2021, In April 2021, In April 2021, three first January 1, 2022, second January 1, 2023 third January 1, 2024. In March 2021, four first June 30, 2021, second September 30, 2021, third December 31, 2021, fourth March 31, 2022. In March 2021, July December 2021. In January 2021, 15 April 6, 2021. In October 2020, three first October 1, 2021, second October 1, 2022 third October 1, 2023 The Company recognized $373,610 and $1,626,613 of restricted stock compensation expense for the years ended September 30, 2022 2021

Note 10 - Warrants

Note 10 - Warrants	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Warrants Disclosure [Text Block]	NOTE 10 WARRANTS Transactions involving the Company equity-classified warrants for the fiscal years ended September 30, 2022 2021 Weighted-average remaining Aggregate Weighted-average contractual term intrinsic value Number of shares exercise price (in years) (in thousands) Outstanding at September 30, 2020 914,184 $ 3.88 3.23 $ - Granted 293,984 3.75 - Exercised (323,444 ) 1.25 Forfeited (224,307 ) 5.39 Outstanding at September 30, 2021 660,417 4.60 3.05 - Granted - - - Exercised - - Forfeited (70,500 ) 4.00 Outstanding at September 30, 2022 589,917 4.68 2.30 - Exercisable at September 30, 2022 589,917 $ 4.68 - $ - The following table summarizes outstanding common stock purchase warrants as of September 30, 2022 Weighted-average Number of shares exercise price Expiration Exercisable at $7.50 per share 100,000 7.50 October 2022 Exercisable at $4.375 per share 51,429 4.375 September 2023 Exercisable at $7.50 per share 60,000 7.50 May 2024 Exercisable at $3.9125 per share 47,822 3.9125 October 2024 Exercisable at $1.25 per share 36,682 1.25 January 2025 Exercisable at $3.74 per share 150,502 3.74 December 2025 Exercisable at $3.75 per share 143,482 3.75 June 2026 589,917 $ 4.68

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 11 COMMITMENTS AND CONTINGENCIES In May 2019, December 31, 2022 December 2019 - December 2020 - December 2021 - December 2022 - 19 March 2020 June 2020. July 1, 2020, July 2020 December 2022 – three two July 2020, July 2021 December 2021, July 2022 December 2022. July 2020 December 2020 - January 2021 June 2021 - July 2021 December 2021 - January 2022 June 2022 - July 2022 December 2022 - March 2021, July 2021 December 2021. January 2022, December 2024. 2022 2024, September 30, 2022 2021, November 4, 2022, November 2022. No one In April 2022, February 2022, February 2025 As previously disclosed, during June 2022, June 2022 not

Note 12 - Note Payable

Note 12 - Note Payable	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 12 NOTE PAYABLE In July 2019, April 2022, September 30, 2022. January 2020, September 30, 2022.

Note 13 - Paycheck Protection P

Note 13 - Paycheck Protection Program Loan	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Short-Term Debt [Text Block]	NOTE 13 PAYCHECK PROTECTION PROGRAM LOAN In April 2020, 1106 April 27, 2020, May 2021,

Note 14 - Leases

Note 14 - Leases	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	NOTE 14 LEASES The Company has lease agreements for its corporate, warehouse and laboratory offices with lease periods expiring between 2024 2026. 842 not Right-of-use lease assets and corresponding lease liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term. Since the interest rate implicit in our lease arrangements is not may In addition to the monthly base amounts in the lease agreements, the Company is required to pay real estate taxes, insurance and common area maintenance expenses during the lease terms. Lease costs on operating leases are recognized on a straight-line basis over the lease term and included as a selling, general and administrative expense in the consolidated statements of operations. Components of operating lease costs are summarized as follows: Year Ended September 30, 2022 Total Operating Lease Costs $ 1,391,856 Supplemental cash flow information related to operating leases is summarized as follows: Year Ended September 30, 2022 Cash paid for amounts included in the measnurement of operating lease liabilities $ 1,405,887 As of September 30, 2022 September 30, 2022 For the year ended September 30, 2023 1,380,204 2024 1,421,610 2025 1,159,949 Thereafter 1,372,862 Total future lease payments 5,334,625 Less interest (475,567 ) Total lease liabilities $ 4,859,058 Future minimum lease payments (including interest) under non-cancelable operating leases as of September 30, 2021 For the year ended September 30, 2022 $ 1,405,887 2023 1,380,204 2024 1,421,610 2025 1,159,949 Thereafter 1,372,862 Total futrue lease payments 6,740,512 Less interest (730,304 ) Total lease liabilities $ 6,010,208

Note 15 - Loss Per Share

Note 15 - Loss Per Share	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 15 LOSS PER SHARE The following table sets forth the computation of basic and diluted earnings per share for the following periods: Year Ended September 30, September 30, 2022 2021 Basic: Net income (loss) $ (70,083,693 ) $ (23,394,889 ) Preferred dividends paid 4,002,005 2,554,609 Net income (loss) continuing operations adjusted for preferred dividend (74,085,698 ) (25,949,498 ) Net income (loss) attributable to cbdMD Inc. common shareholders (74,085,698 ) (25,949,498 ) Diluted: Net income (loss) (74,085,698 ) (25,949,498 ) Net income (loss) (74,085,698 ) (25,949,498 ) Shares used in computing basic earnings per share 59,750,301 54,938,128 Effect of dilutive securities: Options - - Warrants - - Convertible preferred shares - - Shares used in computing diluted earnings per share 59,750,301 54,938,128 Earnings per share Basic: Continued operations (1.24 ) (0.47 ) Discontinued operations - - Basic earnings per share (1.24 ) (0.47 ) Earnings per share Dliuted: Continued operations (1.24 ) (0.47 ) Discontinued operations - - Diluted earnings per share (1.24 ) (0.47 ) At the year ended September 30, 2022

Note 16 - Income Taxes

Note 16 - Income Taxes	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 16 INCOME TAXES The Company generated operating losses for the years ended September 30, 2022 2021 The following table presents the components of the provision for income taxes from continuing operations for the fiscal years ended September 30, 2022 2021 Year Ended September 30, 2022 2021 Current Federal $ - $ - State - - Total current - - Deferred Federal - (895,000 ) State - - Total deferred - (895,000 ) Total provision $ - $ (895,000 ) A reconciliation for the federal statutory income tax rate to the Company’s effective income tax rate is as follows: Year Ended September 30, 2022 2021 Federal statutory income tax rate 21.0 % 21.0 % State income taxes, net of federal benefit 0.4 0.8 Permanent differences (17.1 ) 1.5 Contingent derivative expense 2.5 (5.8 ) Limitation on net operating losses - - Change in valuation allowance (6.8 ) (13.8 ) Benefit from (provision for) income taxes 0.0 % 3.7 % Significant components of the Company’s deferred income taxes are shown below: Year Ended September 30, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 12,909,000 $ 9,160,000 ROU - Liability 1,087,000 1,342,000 Capital loss carryforward 702,000 716,000 Allowance for doubtful accounts 8,000 1,000 Stock compensation 833,000 1,107,000 Investments 452,000 444,000 Accrued expenses 214,000 165,000 Fixed Assets 40,000 - Inventory reserve 35,000 16,000 Capitalized expenses 48,000 52,000 Charitable contributions 45,000 43,000 Total deferred tax assets 16,373,000 13,046,000 Deferred tax liabilities: Prepaid Expenses (257,000 ) (219,000 ) ROU - Assets (1,002,000 ) (1,254,000 ) Intangibles (3,426,000 ) (4,481,000 ) Fixed assets - (162,000 ) Total deferred tax liabilities (4,685,000 ) (6,116,000 ) Net deferred tax assets 11,688,000 6,930,000 Valuation allowance (11,688,000 ) (6,930,000 ) Net deferred tax liability $ - $ - Net deferred tax liability The Company has established a valuation allowance against net deferred tax assets due to the uncertainty that such assets will be realized. The deferred tax liabilities that result from indefinite life intangibles cannot be offset by deferred tax assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than not 382, may September 30, 2018, 382 September 30, 2017 2015. September 30, 2018 382. During the year ended September 30, 2021 September 30, 2019. September 30, 2021 382. The total valuation allowance increased by $4,758,000 and decreased by $3,351,000 as of September 30, 2022 2021 At September 30, 2022 The Company accounts for its state franchise and minimum taxes as a component of its general and administrative expenses. The Company files income tax returns in the United States, and various state jurisdictions. The Company’s policy is to recognize interest expense and penalties related to income tax matters as tax expense. At September 30, 2021 2020 no no The CARES Act, which was enacted on March 27, 2020, no September 30, 2021 may On December 20, 2018, two 2 The Company has had a valuation allowance against the net deferred tax assets, with the exception of the deferred tax liabilities that result from indefinite-life intangibles ("naked credits"). During the year ended September 30, 2021 zero

Note 17 - Acquisitions

Note 17 - Acquisitions	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	NOTE 17 ACQUISITIONS On July 22, 2021, January 31, 2023, 60th first The initial 300,000 shares issued and 100,000 indemnification holdback shares had a carrying value of $1,064,000 and are included in additional paid in capital in the consolidated balance sheet. As of September 30, 2022 not no The following table presents the final purchase price allocation: Consideration $ 3,552,529 Assets Acquired: Undeposited Funds $ 18,155 Inventory 79,895 Inventory - Prepaid Shipping 31,094 Proerpty and equipment, net 5,000 Intangible Assets 3,418,383 Total assets aquired $ 3,552,529

Note 18 - Subsequent Events

Note 18 - Subsequent Events	12 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 18 SUBSEQUENT EVENTS The Company has analyzed its operations subsequent to September 30, 2022 no

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries CBDI, Paw CBD and Therapeutics. All material intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are not On March 11, 2020, 19 19
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents For financial statements purposes, the Company considers all highly liquid investments with a maturity of less than three
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]	Accounts Receivable and Accounts Receivable Other Accounts receivables are stated at cost less an allowance for doubtful accounts, if applicable. Credit is extended to customers after an evaluation of the customer’s financial condition, and generally collateral is not September 30, 2022 September 30, 2021,
Merchant Receivable and Reserve [Policy Text Block]	Merchant Receivable The Company primarily sells its products through the internet and has an arrangement to process customer payments with multiple third 2 5 September 30, 2022,
Inventory, Policy [Policy Text Block]	Inventory Inventory is stated at the lower of cost or net realizable value with cost being determined on a weighted average basis. The cost of inventory includes product cost, freight-in, and production fill and labor (portions of which we outsource to third
Deposit Contracts, Policy [Policy Text Block]	Customer Deposits Customer deposits consist of payments received in advance of revenue recognition. Revenue is recognized as revenue recognition criteria are met.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment items are stated at cost less accumulated depreciation. Expenditures for routine maintenance and repairs are charged to operations as incurred. Depreciation is charged to expense over the estimated useful lives of the assets using the straight-line method. Generally, the useful lives are five three may not
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Accounting The Company utilizes accounting standards for fair value, which include the definition of fair value, the framework for measuring fair value, and disclosures about fair value measurements. Fair value is a market-based measurement, not 1 2 3 Level 1 2 1 2 may 3 When the Company records an investment in marketable securities the carrying value is recorded at fair value. Any changes in fair value for marketable securities during a given period will be recorded as an unrealized gain or loss in the consolidated statement of operations. For investment other securities without a readily determinable fair value, the Company may
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Goodwill represents the excess of cost of an acquired business over the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed in a business combination. Identifiable intangible assets acquired in business combinations are recorded based on their fair values at the date of acquisition. Goodwill is not not In performing a goodwill test, the Company performs a qualitative evaluation and if necessary, a quantitative evaluation. Factors considered in the qualitative test include specific operating results as well as new events and circumstances impacting the operations or cash flows of the business acquired. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of the business to the respective fair value. The Company determines the fair value of its acquired business using a combination of income-based and market-based approaches and incorporates assumptions it believes market participants would utilize. The income-based approach utilizes discounted cash flows while the market-based approach utilizes market capitalization comparisons. These approaches are dependent upon internally developed forecasts that are based upon annual budgets and longer-range strategic plans. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective acquired business and in the internally developed forecasts. The Company has analyzed a variety of factors on its business to determine if a circumstance could trigger an impairment loss. See Note 5
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Intangible Assets The Company's intangible assets consist of trademarks and other intellectual property, all of which were previously accounted for in accordance with Accounting Standards Codification (ASC) Topic 350, Intangibles Goodwill and Other not August 1 350 30 35 18. not not 5 December 31, 2021 360, 20 January 1, 2022 360, may not may not two 360, 360,
Business Combinations Policy [Policy Text Block]	Contingent Liability A significant component of the purchase price consideration for the Company’s acquisition of Cure Based Development includes a fixed number of future shares to be issued as well as a variable number of future shares to be issued based upon the post-acquisition entity reaching certain specified future revenue targets, as further described in Note 6.
Paycheck Protection Program Loan [Policy Text Block]	Paycheck Protection Program Loan On April 27, 2020, May 17, 2021
Revenue [Policy Text Block]	Revenue Recognition Under ASC 606, Revenue from Contracts with Customers, five 606: Performance Obligations A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company meets that obligation when it has shipped products which have been ordered by the customer. The Company has reviewed its various revenue streams for its other contracts under the five Allocation of Transaction Price In the Company’s current business model, it does not Revenue Recognition The Company records revenue from the sale of its products when risk of loss and title to the product are transferred to the customer, which is upon shipping (and is typically FOB shipping) which is when our performance obligation is met. Net sales are comprised of gross revenues less product returns, trade discounts and customer allowances, which include costs associated with off-invoice mark-downs and other price reductions, as well as trade promotions. These incentive costs are recognized at the later of the date on which the Company recognizes the related revenue or the date on which the Company offers the incentive. The Company currently offers a 60 Disaggregated Revenue The Company’s product revenue is generated primarily through two A description of the Company’s principal revenue generating activities are as follows: - E-commerce sales - consumer products sold through the Company’s online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due prior to the date of shipment; and - Wholesale sales - products sold to the Company’s wholesale customers for subsequent resale. Revenue is recognized when control of the goods is transferred to the customer, in accordance with the terms of the applicable agreement. Payment terms vary and can typically be 30 The following table represents a disaggregation of revenue by sales channel: Fiscal 2022 % of total Fiscal 2021 % of total E-commerce sales $ 26,435,203 74.7 % $ 32,907,956 74.0 % Wholesale sales 8,968,021 25.3 % 11,572,807 26.0 % Total Net Sales $ 35,403,224 $ 44,480,763 Contract assets represent unbilled receivables and are presented within accounts receivable, net on the consolidated balance sheets. Contract liabilities represent unearned revenues and are presented as deferred revenue or customer deposits on the consolidated balance sheets. The Company has no September 30, 2022
Cost of Goods and Service [Policy Text Block]	Cost of Sales The Company’s cost of sales includes costs associated with distribution, fill and labor expense, components, manufacturing overhead, third
Advertising Cost [Policy Text Block]	Advertising Costs The Company expenses all costs of advertising and related marketing and promotional costs as incurred. The Company incurred $14,332,235 and $15,835,139 in advertising and marketing and promotional costs included in operating expenses during the years ended September 30, 2022 2021
Income Tax, Policy [Policy Text Block]	Income Taxes The Company is a North Carolina corporation that is treated as a corporation for federal and state income tax purposes. As of October 1, 2019, March 15, 2021, The Company accounts for income taxes pursuant to the provisions of the Accounting for Income Taxes 740 not not US GAAP requires management to evaluate tax positions taken by the Company and recognize a tax liability (or asset) if the Company has taken an uncertain tax position that more likely than not not September 30, 2022 2021 no
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities. The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (“FDIC”) covers $250,000 for substantially all depository accounts. The Company from time to time may September 30, 2022 September 30, 2021 Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did not September 30, 2022
Share-Based Payment Arrangement [Policy Text Block]	Stock-Based Compensation The Company accounts for its stock compensation under the ASC 718 10 30, Compensation - Stock Compensation may The Company uses the Black-Scholes model for measuring the fair value of options and warrants. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. The Company recognizes forfeitures when they occur.
Liquidity and Going Concern Considerations, Policy [Policy Text Block]	Liquidity and Going Concern Considerations The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company experienced a loss of $74,086,731 for the fiscal year ended September 30, 2022. one While the Company is taking strong action, believes in the viability of its strategy and path to profitability, and in its ability to raise additional funds, there can be no may not twelve twelve not may not
Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]	Restructuring The Company recorded a one September 30, 2022.
Earnings Per Share, Policy [Policy Text Block]	Earnings (Loss) Per Share The Company uses ASC 260 10, Earnings Per Share
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Standards In December 2019, 2019 12, 740 740 not not 2019 12 December 15, 2020, no

Note 1 - Organization and Sum_2

Note 1 - Organization and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Disaggregation of Revenue [Table Text Block]	Fiscal 2022 % of total Fiscal 2021 % of total E-commerce sales $ 26,435,203 74.7 % $ 32,907,956 74.0 % Wholesale sales 8,968,021 25.3 % 11,572,807 26.0 % Total Net Sales $ 35,403,224 $ 44,480,763

Note 2 - Marketable Securitie_2

Note 2 - Marketable Securities and Investment Other Securities (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	In Active Markets for Significant Other Identical Assets Observable Total Fair Value and Liabilities Inputs at September 30, (Level 1) (Level 2) 2022 Balance at September 30, 2020 $ 26,472 $ - $ 26,472 Change in value of equities 6,879 - 6,879 Additional Investment - - - Balance at September 30, 2021 33,351 - 33,351 Change in value of equities (33,351 ) (33,351 ) Additional Investment - - Balance at September 30, 2022 $ - $ - $ -

Note 3 - Inventory (Tables)

Note 3 - Inventory (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Inventory, Current [Table Text Block]	Septmeber 30 September 30, 2022 2021 Finished Goods $ 3,198,488 $ 3,362,897 Inventory Components 1,213,724 1,729,176 Inventory Reserve (156,298 ) (70,206 ) Inventory prepaid 511,459 551,519 Total Inventory $ 4,767,373 $ 5,573,386

Note 4 - Property and Equipme_2

Note 4 - Property and Equipment (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 30, September 30, 2022 2021 Computers, furniture and equipment $ 1,095,228 $ 549,910 Manufacturing equipment 284,275 2,968,838 Leasehold improvements 487,081 870,621 Automobiles 11,087 35,979 1,877,671 4,425,348 Less accumulated depreciation (1,054,361 ) (1,863,774 ) Property and equipment, net $ 823,310 $ 2,561,574

Note 5 - Goodwill and Intangi_2

Note 5 - Goodwill and Intangible Assets (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Intangible Assets and Goodwill [Table Text Block]	September 30, September 30, 2022 2021 Trademark related to cbdMD $ 21,585,000 $ 21,585,000 Trademark for HempMD 50,000 50,000 Technology Relief from Royalty related to DirectCBDOnline.com 667,844 667,844 Tradename related to DirectCBDOnline.com 749,567 749,567 Impairment of definite lived intanigble assets: (4,285,000 ) - Amortization of definite lived intangible assets: (932,862 ) (48,482 ) Total $ 17,834,549 $ 23,003,929
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	For the year ended September 30, 2023 1,109,418 2024 1,109,418 2025 1,074,634 2026 942,457 2027 942,457 Thereafter 12,656,165 Total future intangibles amortization $ 17,834,549
Schedule of Goodwill [Table Text Block]	Goodwill at September 30, 2021 $ 56,670,970 Impairment of goodwill (56,670,970 ) Goodwill at September 30, 2022 $ -

Note 6 - Contingent Liability (

Note 6 - Contingent Liability (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]	Aggregate Net Revenues Shares Issued/ Each $ of Aggregate Net Revenue Ratio $1 - $20,000,000 .190625 $20,000,001 - $60,000,000 .0953125 $60,000,001 - $140,000,000 .04765625 $140,000,001 - $300,000,000 .23828125

Note 8 - Shareholders' Equity (

Note 8 - Shareholders' Equity (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	2022 2021 Weighted average exercise price $ 0.99 $ 3.91 Risk free interest rate 2.56% - 2.97% 0.16% - 0.85% Volatility 101.23% - 103.98% 100.72% Expected term (in years) 2.5 - 5.5 2.5 - 5.5 Divident yield None None 2022 2021 Weighted average exercise price $ - $3.74 Risk free interest rate 0.00 % 0.39% - 0.89% Volatility 0.00 % 103.42 % Expected term (in years) - 2.75 Divident yield - None

Note 9 - Stock-Based Compensa_2

Note 9 - Stock-Based Compensation (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted-average remaining Aggregate Weighted-average contractual term intrinsic value Number of shares exercise price (in years) (in thousands) Outstanding at September 30, 2020 1,750,000 $ 4.68 $ - Granted 1,380,000 3.91 - Exercised (147,953 ) 2.60 Forfeited (279,547 ) 4.47 Outstanding at September 30, 2021 2,702,500 4.42 5.13 - Granted 1,060,000 0.97 - Exercised - - Forfeited (1,260,000 ) 3.63 Outstanding at September 30, 2022 2,502,500 3.36 4.55 - Exercisable at September 30, 2022 1,549,167 $ 4.13 4.69 $ -

Note 10 - Warrants (Tables)

Note 10 - Warrants (Tables)	12 Months Ended
	Sep. 30, 2022
Common Stock Purchase Warrants [Member]
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Weighted-average Number of shares exercise price Expiration Exercisable at $7.50 per share 100,000 7.50 October 2022 Exercisable at $4.375 per share 51,429 4.375 September 2023 Exercisable at $7.50 per share 60,000 7.50 May 2024 Exercisable at $3.9125 per share 47,822 3.9125 October 2024 Exercisable at $1.25 per share 36,682 1.25 January 2025 Exercisable at $3.74 per share 150,502 3.74 December 2025 Exercisable at $3.75 per share 143,482 3.75 June 2026 589,917 $ 4.68
Equity Classified Warrants [Member]
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Weighted-average remaining Aggregate Weighted-average contractual term intrinsic value Number of shares exercise price (in years) (in thousands) Outstanding at September 30, 2020 914,184 $ 3.88 3.23 $ - Granted 293,984 3.75 - Exercised (323,444 ) 1.25 Forfeited (224,307 ) 5.39 Outstanding at September 30, 2021 660,417 4.60 3.05 - Granted - - - Exercised - - Forfeited (70,500 ) 4.00 Outstanding at September 30, 2022 589,917 4.68 2.30 - Exercisable at September 30, 2022 589,917 $ 4.68 - $ -

Note 14 - Leases (Tables)

Note 14 - Leases (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Lease, Cost [Table Text Block]	Year Ended September 30, 2022 Total Operating Lease Costs $ 1,391,856 Year Ended September 30, 2022 Cash paid for amounts included in the measnurement of operating lease liabilities $ 1,405,887
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	For the year ended September 30, 2023 1,380,204 2024 1,421,610 2025 1,159,949 Thereafter 1,372,862 Total future lease payments 5,334,625 Less interest (475,567 ) Total lease liabilities $ 4,859,058 For the year ended September 30, 2022 $ 1,405,887 2023 1,380,204 2024 1,421,610 2025 1,159,949 Thereafter 1,372,862 Total futrue lease payments 6,740,512 Less interest (730,304 ) Total lease liabilities $ 6,010,208

Note 15 - Loss Per Share (Table

Note 15 - Loss Per Share (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Year Ended September 30, September 30, 2022 2021 Basic: Net income (loss) $ (70,083,693 ) $ (23,394,889 ) Preferred dividends paid 4,002,005 2,554,609 Net income (loss) continuing operations adjusted for preferred dividend (74,085,698 ) (25,949,498 ) Net income (loss) attributable to cbdMD Inc. common shareholders (74,085,698 ) (25,949,498 ) Diluted: Net income (loss) (74,085,698 ) (25,949,498 ) Net income (loss) (74,085,698 ) (25,949,498 ) Shares used in computing basic earnings per share 59,750,301 54,938,128 Effect of dilutive securities: Options - - Warrants - - Convertible preferred shares - - Shares used in computing diluted earnings per share 59,750,301 54,938,128 Earnings per share Basic: Continued operations (1.24 ) (0.47 ) Discontinued operations - - Basic earnings per share (1.24 ) (0.47 ) Earnings per share Dliuted: Continued operations (1.24 ) (0.47 ) Discontinued operations - - Diluted earnings per share (1.24 ) (0.47 )

Note 16 - Income Taxes (Tables)

Note 16 - Income Taxes (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Year Ended September 30, 2022 2021 Current Federal $ - $ - State - - Total current - - Deferred Federal - (895,000 ) State - - Total deferred - (895,000 ) Total provision $ - $ (895,000 )
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Year Ended September 30, 2022 2021 Federal statutory income tax rate 21.0 % 21.0 % State income taxes, net of federal benefit 0.4 0.8 Permanent differences (17.1 ) 1.5 Contingent derivative expense 2.5 (5.8 ) Limitation on net operating losses - - Change in valuation allowance (6.8 ) (13.8 ) Benefit from (provision for) income taxes 0.0 % 3.7 %
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Year Ended September 30, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 12,909,000 $ 9,160,000 ROU - Liability 1,087,000 1,342,000 Capital loss carryforward 702,000 716,000 Allowance for doubtful accounts 8,000 1,000 Stock compensation 833,000 1,107,000 Investments 452,000 444,000 Accrued expenses 214,000 165,000 Fixed Assets 40,000 - Inventory reserve 35,000 16,000 Capitalized expenses 48,000 52,000 Charitable contributions 45,000 43,000 Total deferred tax assets 16,373,000 13,046,000 Deferred tax liabilities: Prepaid Expenses (257,000 ) (219,000 ) ROU - Assets (1,002,000 ) (1,254,000 ) Intangibles (3,426,000 ) (4,481,000 ) Fixed assets - (162,000 ) Total deferred tax liabilities (4,685,000 ) (6,116,000 ) Net deferred tax assets 11,688,000 6,930,000 Valuation allowance (11,688,000 ) (6,930,000 ) Net deferred tax liability $ - $ -

Note 17 - Acquisitions (Tables)

Note 17 - Acquisitions (Tables)	12 Months Ended
	Sep. 30, 2022
Notes Tables
Asset Acquisition [Table Text Block]	Consideration $ 3,552,529 Assets Acquired: Undeposited Funds $ 18,155 Inventory 79,895 Inventory - Prepaid Shipping 31,094 Proerpty and equipment, net 5,000 Intangible Assets 3,418,383 Total assets aquired $ 3,552,529

Note 1 - Organization and Sum_3

Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)			1 Months Ended				6 Months Ended	9 Months Ended	12 Months Ended
	May 21, 2021 USD ($)	Apr. 27, 2020 USD ($)	May 31, 2022 shares	Mar. 31, 2022 shares	Dec. 31, 2021 shares	Apr. 30, 2019 shares	Jun. 30, 2022 shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($)
Accounts Receivable, Allowance for Credit Loss, Ending Balance								$ 36,980	$ 36,980	$ 3,633
Accounts Receivable, after Allowance for Credit Loss, Current, Total								273,451	273,451
Gain (Loss) on Extinguishment of Debt, Total									0	1,466,113
Revenue, Remaining Performance Obligation, Amount								0	0
Contract with Customer, Asset, after Allowance for Credit Loss, Total								0	0
Contract with Customer, Liability, Total										0
Marketing and Advertising Expense, Total									14,332,235	15,835,139
Federal Deposit Insurance Corporation Premium Expense										250,000
Cash, Uninsured Amount								5,752,550	5,752,550	23,508,953
Net Income (Loss) Including Impairment									(74,086,731)
Goodwill and Intangible Asset Impairment, Total									60,955,970	$ 0
Net Income (Loss), Excluding Impairment									(13,130,761)
Working Capital								$ 10,725,991	10,725,991
Restructuring Costs, Total									$ 602,092
Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member]
Number of Major Customers										0
Paycheck Protection Program CARES Act [Member]
Proceeds from Issuance of Debt		$ 1,456,100
Gain (Loss) on Extinguishment of Debt, Total	$ 1,466,113
Manufacturing Equipment [Member]
Property, Plant and Equipment, Useful Life (Year)									5 years
Software [Member]
Property, Plant and Equipment, Useful Life (Year)									3 years
Minimum [Member]
MerchantProcessingFee								2.50%	2.50%
Maximum [Member]
MerchantProcessingFee								5%	5%
Cure Based Development, Llc [Member] | Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares						15,250,000
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)						5 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares) | shares			458,877	444,243	466,713	15,250,000	409,505	3,928,792
Cure Based Development, Llc [Member] | Unregistered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares						8,750,000			2,187,500
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)						5 years

Note 1 - Organization and Sum_4

Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Revenues, Total	$ 35,403,224	$ 44,480,763
Sales Channel [Member] | Revenue Benchmark [Member]
Concentration Risk, Percentage
Sales Channel, Directly to Consumer [Member]
Revenues, Total	$ 26,435,203	$ 32,907,956
Sales Channel, Directly to Consumer [Member] | Sales Channel [Member] | Revenue Benchmark [Member]
Concentration Risk, Percentage	74.70%	74%
Sales Channel, Through Intermediary [Member]
Revenues, Total	$ 8,968,021	$ 11,572,807
Sales Channel, Through Intermediary [Member] | Sales Channel [Member] | Revenue Benchmark [Member]
Concentration Risk, Percentage	25.30%	26%

Note 2 - Marketable Securitie_3

Note 2 - Marketable Securities and Investment Other Securities (Details Textual) - USD ($)			1 Months Ended	12 Months Ended
	Apr. 07, 2022	Mar. 24, 2021	Sep. 30, 2020	Sep. 30, 2022	Sep. 30, 2021	Jan. 13, 2021
Marketable Securities, Realized Gain (Loss)				$ 33,350	$ 546,878
Steady State, LLC [Member]
Equipment Sold Value	$ 1,800,000
Investments, Total	$ 1,400,000
Adara Sponser L L C [Member]
Share Price (in dollars per share)				$ 2,023
Adara Sponser L L C [Member]
Payments to Acquire Additional Interest in Subsidiaries			$ 250,000
Common Stock, Value, Subscriptions						$ 750,000
Initial Public Offering Shares (in shares)		11,500,000

Note 2 - Marketable Securitie_4

Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Fair Value, Inputs, Level 1 [Member]
Balance	$ 33,351	$ 26,472
Change in value of equities	(33,351)	6,879
Additional Investment	0	0
Balance	0	33,351
Fair Value, Inputs, Level 2 [Member]
Balance	0	0
Change in value of equities		0
Additional Investment		0
Balance	0	0
Fair Value, Inputs, Level 3 [Member]
Balance	33,351	26,472
Change in value of equities	(33,351)	6,879
Additional Investment	0	0
Balance	$ 0	$ 33,351

Note 3 - Inventory (Details Tex

Note 3 - Inventory (Details Textual) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Inventory Write-down	$ 878,142	$ 878,142	$ 670,580

Note 3 - Inventory - Schedule o

Note 3 - Inventory - Schedule of Inventory (Details) - USD ($)	Sep. 30, 2022	Sep. 30, 2021
Finished Goods	$ 3,198,488	$ 3,362,897
Inventory Components	1,213,724	1,729,176
Inventory Reserve	(156,298)	(70,206)
Inventory prepaid	511,459	551,519
Total Inventory	$ 4,767,373	$ 5,573,386

Note 4 - Property and Equipme_3

Note 4 - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Depreciation, Excluding Lessor Asset under Operating Lease	$ 948,962	$ 1,017,408

Note 4 - Property and Equipme_4

Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details) - USD ($)	Sep. 30, 2022	Sep. 30, 2021
Property and equipment, gross	$ 1,877,671	$ 4,425,348
Less accumulated depreciation	(1,054,361)	(1,863,774)
Property and equipment, net	823,310	2,561,574
Computers, Furniture, and Equipment [Member]
Property and equipment, gross	1,095,228	549,910
Manufacturing Equipment [Member]
Property and equipment, gross	284,275	2,968,838
Leasehold Improvements [Member]
Property and equipment, gross	487,081	870,621
Automobiles [Member]
Property and equipment, gross	$ 11,087	$ 35,979

Note 5 - Goodwill and Intangi_3

Note 5 - Goodwill and Intangible Assets (Details Textual) - USD ($)			1 Months Ended		3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Jan. 31, 2022	Jul. 31, 2021	Dec. 31, 2021	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2019
Goodwill, Ending Balance	$ 0						$ 0	$ 56,670,970
Goodwill, Impairment Loss	11,996,249				$ 13,898,285	$ 30,776,436	56,670,970
Intangible Assets, Net (Excluding Goodwill), Total	$ 17,834,549						17,834,549	23,003,929
Impairment of Intangible Assets, Finite-Lived							4,285,000	0
Amortization of Intangible Assets							884,380	$ 0
Trademark Related to Hemp MD [Member]
Intangible Assets, Net (Excluding Goodwill), Total									$ 50,000
Trademarks [Member]
Finite-Lived Intangible Asset, Useful Life (Year)		20 years	20 years	10 years
Amortization of Intangible Assets							$ 932,862
Developed Technology Rights [Member]
Finite-Lived Intangible Asset, Useful Life (Year)				4 years
Trademark Related to cbdMD [Member]
Impairment of Intangible Assets, Finite-Lived		$ 4,285,000

Note 5 - Goodwill and Intangi_4

Note 5 - Goodwill and Intangible Assets - Schedule of Intangible Assets and Goodwill (Details) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Impairment of definite lived intanigble assets:	$ (4,285,000)	$ 0
Amortization of definite lived intangible assets:	(932,862)	(48,482)
Intangible Assets, Net (Excluding Goodwill), Total	17,834,549	23,003,929
Technology Relief From Royalty Related To Direct C B D Online Com Member
Definite lived intangible assets	667,844	667,844
Tradename Related To Direct C B D Online Com Member
Definite lived intangible assets	749,567	749,567
Trademark Related to cbdMD [Member]
Indefinite lived trademark	21,585,000	21,585,000
Trademark Related to Hemp MD [Member]
Indefinite lived trademark	$ 50,000	$ 50,000

Note 5 - Goodwill and Intangi_5

Note 5 - Goodwill and Intangible Assets - Future Amortization of Intangible Assets (Details)	Sep. 30, 2022 USD ($)
2023	$ 1,109,418
2024	1,109,418
2025	1,074,634
2026	942,457
2027	942,457
Thereafter	12,656,165
Total future intangibles amortization	$ 17,834,549

Note 5 - Goodwill and Intangi_6

Note 5 - Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($)		3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Jun. 30, 2022	Sep. 30, 2022
Goodwill		$ 56,670,970	$ 56,670,970	$ 56,670,970
Impairment of goodwill	$ (11,996,249)	$ (13,898,285)	$ (30,776,436)	(56,670,970)
Goodwill	$ 0			$ 0

Note 6 - Contingent Liability_2

Note 6 - Contingent Liability (Details Textual) - USD ($)					1 Months Ended						6 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Apr. 19, 2019	Dec. 20, 2018	May 31, 2022	Apr. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jul. 31, 2021	Apr. 30, 2019	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Nov. 30, 2021
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability														$ (8,473,999)	$ 6,687,439
Business Combination, Contingent Consideration, Liability, Noncurrent		$ 9,856,000										$ 276,000		276,000	9,856,000
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)																120,000
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Terms, Generated Net Sales, Amount													$ 3,000,000
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Terms, Generated Net Sales, Amount													$ 8,000,000
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee (in shares)						100,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Minimum Consumer Revenue Required						$ 12,000,000
Employee-related Liabilities, Total												$ 0		$ 0
Cure Based Development, Llc [Member] | Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)										15,250,000
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)										5 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)					458,877		444,243	466,713		15,250,000	409,505	3,928,792
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares, Expiration (Month)				60 months
Long-Term Debt, Gross										$ 53,215,163
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			$ 53,215,163
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability					$ 90,792	17,718	$ 41,914	$ (366,841)
Business Combination, Contingent Consideration, Liability, Current	$ 405,000				$ 178,000	$ 198,000	325,000	405,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Remaining Earnout Shares Subject to Issuance (in shares)												3,928,797		3,928,797
Business Combination, Contingent Consideration, Liability, Noncurrent		9,440,000										$ 276,000		$ 276,000	9,440,000
Cure Based Development, Llc [Member] | Registered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)										6,500,000
Cure Based Development, Llc [Member] | Unregistered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)										8,750,000				2,187,500
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)										5 years
Twenty Two Acquisition [Member] | Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)									200,000
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	(255,000)	(73,561)					148,000							$ 13,000
Business Combination, Contingent Consideration, Liability, Noncurrent	$ 161,000	$ 416,000					$ 13,000	$ 161,000	$ 488,561			$ 0		$ 0	$ 416,000

Note 6 - Contingent Liability -

Note 6 - Contingent Liability - Contingent Liability (Details)	12 Months Ended
	Sep. 30, 2022
Earnout Shares for Revenue Between $1 and $20,000,000 [Member]
Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio	0.190625
Earnout Shares for Revenue Between $20,000,001 and $60,000,000 [Member]
Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio	0.0953125
Earnout Shares for Revenue Between $60,000,001 and $140,000,000 [Member]
Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio	0.04765625
Earnout Shares for Revenue Between $140,000,001 and $300,000,000 [Member]
Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio	0.23828125

Note 8 - Shareholders' Equity_2

Note 8 - Shareholders' Equity (Details Textual) - USD ($)									1 Months Ended																		3 Months Ended								6 Months Ended	9 Months Ended	12 Months Ended
	Dec. 28, 2021	Aug. 16, 2021	Jul. 22, 2021	Jul. 02, 2021	Jun. 30, 2021	Jun. 08, 2021	May 14, 2021	Apr. 09, 2021	Aug. 31, 2022	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022	Mar. 31, 2022	Jan. 31, 2022	Nov. 30, 2021	Oct. 31, 2021	Jul. 30, 2021	Jul. 22, 2021	Jun. 30, 2021	Apr. 30, 2021	Mar. 31, 2021	Feb. 28, 2021	Jan. 31, 2021	Oct. 31, 2020	Jul. 31, 2020	Oct. 31, 2019	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Jun. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jul. 01, 2021
Preferred Stock, Shares Authorized (in shares)																											50,000,000				50,000,000						50,000,000	50,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)																											$ 0.001				$ 0.001						$ 0.001	$ 0.001
Preferred Stock, Shares Issued (in shares)																											5,000,000				5,000,000						5,000,000	5,000,000
Preferred Stock, Shares Outstanding, Ending Balance (in shares)																											500,000				500,000						500,000	500,000
Common Stock, Shares Authorized (in shares)																											150,000,000				150,000,000						150,000,000	150,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)																											$ 0.001				$ 0.001						$ 0.001	$ 0.001
Common Stock, Shares, Issued (in shares)			300,000															300,000									60,665,595				57,783,340						60,665,595	57,783,340
Proceeds from Issuance of Preferred Stock and Preference Stock																																					$ 0	$ 30,938,386
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)	466,713
Stock Issued During Period, Value, Restricted Stock Award, Gross																$ 25,000											$ 129,960	$ (593,617)	$ 328,514	$ 508,754	$ 479,899	$ 590,292	$ 1,181,828	$ 15,279
Class of Warrant or Right, Unissued (in shares)																											323,444										323,444
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)																											$ 1.25										$ 1.25
Stock Issued During Period, Shares, Acquisitions (in shares)			600,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)																																					1,060,000	1,380,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)																																					1,260,000	279,547
Stock or Unit Option Plan Expense																																					$ 555,215	$ 1,298,106
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)																																					$ 0.97	$ 3.91
Common Stock, Shares, Outstanding, Ending Balance (in shares)																											60,665,595				57,783,340						60,665,595	57,783,340
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																																					1 year
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)																																					5 years
Prepaid Expense in Conjunction With the Issuances of Shares [Member]
Prepaid Expense						$ 80,500		$ 143,600														$ 155,200
Twenty Two Acquisition [Member]
Stock Issued During Period, Shares, Acquisitions (in shares)																		300,000
Professional Athlete [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)																																						180,000
Stock Issued During Period, Shares, Issued for Services (in shares)														320,000																			320,000		180,000
Stock Issued During Period, Value, Issued for Services														$ 336,000											$ 1,400,000										$ 800,000			$ 800,000
Share-Based Payment Arrangement, Expense																																						850,000
Professional Athlete [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]
Prepaid Expense																					$ 649,800												$ 649,800
Board of Directors [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)													20,000								27,000
Stock Issued During Period, Value, Restricted Stock Award, Gross													$ 16,360								$ 118,800
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)													120,000								150,000
Option Indexed to Issuer's Equity, Strike Price (in dollars per share)													$ 0.818								$ 4.40
Board of Directors [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage													25%
Board of Directors [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage													25%
Board of Directors [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage													25%
Executive Officer [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)											125,000					25,000			25,000	750,000				50,000
Stock Issued During Period, Value, Restricted Stock Award, Gross																								$ 100,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																4 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)																				750,000				350,000
Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)																								$ 3.50
Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)																								5
Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)																								$ 6.50
A New Executive [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)									30,000		405,000
Option Indexed to Issuer's Equity, Strike Price (in dollars per share)									$ 0.568		$ 0.84
Chief Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)																75,000
Representative of the Underwriters [Member] | Warrants to Purchase Common Stock [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)																																		$ 3.74
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																																		150,502
Share-Based Payment Arrangement, Employee [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)											5,000			30,000	120,000	5,000							167,500
Stock Issued During Period, Value, Restricted Stock Award, Gross											$ 3,350			$ 29,250									$ 494,125
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)												100,000		130,000									80,000
Option Indexed to Issuer's Equity, Strike Price (in dollars per share)												$ 1
Share-Based Payment Arrangement, Expense												$ 0
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)																							$ 3.10
Common Stock Earnout Shares [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)		503,275					562,278		409,505		458,887		444,243								3,348,520
Personal Services Agreement for Endorsement [Member]
Stock Issued During Period, Shares, Issued for Services (in shares)																						40,000
Consultant [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)						25,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)												200,000
Option Indexed to Issuer's Equity, Strike Price (in dollars per share)												$ 1
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)												5 years
Share-Based Payment Arrangement, Expense												$ 131,300
Consultant [Member] | Vesting 6 Months From Effective Date [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares (in shares)												50,000
Consultant [Member] | Vesting Upon Renewal of Consulting Agreement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares (in shares)												100,000
Professional Athlete [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)								40,000												40,000	180,000
Stock Issued During Period, Value, Restricted Stock Award, Gross																					$ 800,000
Former Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)										750,000
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount										$ 555,286																		$ 555,286
Equity Compensation Plan [Member] | Consultant [Member]
Stock Issued During Period, Shares, Issued for Services (in shares)									100,000
Stock Issued During Period, Value, Issued for Services									$ 41,000
Director [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)									5,000
Stock Issued During Period, Value, Restricted Stock Award, Gross									$ 2,854
Restricted Stock [Member]
Share-Based Payment Arrangement, Expense																																					$ 373,610	$ 1,626,613
Restricted Stock [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]
Prepaid Expense					$ 80,500														$ 80,500													80,500				$ 80,500
Restricted Stock [Member] | Board of Directors [Member]
Stock Issued During Period, Value, Restricted Stock Award, Gross																				$ 2,520,000
Stock Issued During Period, Value, Issued for Services																					$ 118,800
Restricted Stock [Member] | Board of Directors [Member] | Vesting June, 30, 2021 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage																					25%
Restricted Stock [Member] | Board of Directors [Member] | Vesting September, 30, 2021 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage																					25%
Restricted Stock [Member] | Board of Directors [Member] | Vesting on December 31, 2021 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage																					25%
Restricted Stock [Member] | Board of Directors [Member] | Vesting on March 31, 2022 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage																					25%
Restricted Stock [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																								1 year
Restricted Stock [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																								1 year
Restricted Stock [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																								2 years
Restricted Stock [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																								3 years
Restricted Stock [Member] | Professional Athlete [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]
Prepaid Expense																				$ 143,600
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)																											$ 0.99				$ 3.91						$ 0.99	$ 3.91
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																			12 months
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount																											$ 301,126										$ 301,126
Share-Based Payment Arrangement, Option [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]
Prepaid Expense					$ 125,250														$ 125,250													$ 125,250				$ 125,250
Share-Based Payment Arrangement, Option [Member] | Board of Directors [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)													5 years								5 years
Share-Based Payment Arrangement, Option [Member] | Board of Directors [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]
Prepaid Expense													$ 57,000								$ 395,850								$ 57,000				$ 395,850
Share-Based Payment Arrangement, Option [Member] | Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)																								5 years
Share-Based Payment Arrangement, Option [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																								1 year
Share-Based Payment Arrangement, Option [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																								2 years
Share-Based Payment Arrangement, Option [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)																								3 years
Share-Based Payment Arrangement, Option [Member] | A New Executive [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)									5 years		5 years
Share-Based Payment Arrangement, Expense									$ 10,290		$ 176,985
Share-Based Payment Arrangement, Option [Member] | Chief Executive Officer [Member]
Share-Based Payment Arrangement, Expense																											$ 23,025										46,050
Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)																							10 years
Share-Based Payment Arrangement, Expense														$ 79,500
Share-Based Payment Arrangement, Option [Member] | Consultant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period (in shares)																			50,000
Share-Based Payment Arrangement, Option [Member] | Former Executive Officer [Member]
Share-Based Payment Arrangement, Reversal of Expense										$ 604,714
Series A Cumulative Convertible Preferred Stock [Member] | In October Two Thousand Nineteen [Member]
Preferred Stock, Dividend Rate, Percentage				8%
Proceeds from Issuance of Preferred Stock and Preference Stock				$ 16,500,000
In October Two Thousand Nineteen [Member] | Series A Cumulative Convertible Preferred Stock [Member]
Preferred Stock, Dividend Rate, Percentage																	8%
Underwriting Commisions Shares (in shares)				2,200,000
Increase (Decrease) in Receivables, Total				$ 15,300,000
Aggregate Shares Of Common Stock (in shares)				143,382													143,482
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)																																							$ 3.75
Aggregate Shares Of Common Stock Amount				$ 244,637
Stock or Unit Option Plan Expense																																					124,217
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)																	$ 3.75
In April Two Thousand Twenty One Member
Stock or Unit Option Plan Expense																																					578,963
In January Two Thousand Twenty One [Member]
Stock or Unit Option Plan Expense																																					$ 116,735
Series A Cumulative Convertible Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)																										5,000,000
Preferred Stock, Dividend Rate, Percentage					8%																					8%										8%
Preferred Stock, Shares Issued (in shares)																											5,000,000				5,000,000						5,000,000	5,000,000
Preferred Stock, Shares Outstanding, Ending Balance (in shares)																											500,000				500,000						500,000	500,000
Dividends, Cash, Total																																					$ 4,002,005	$ 2,554,609

Note 8 - Shareholders' Equity -

Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details)	12 Months Ended
	Sep. 30, 2022 $ / shares	Sep. 30, 2021 $ / shares
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input	0
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Measurement Input	0.0039
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member]
Measurement Input		0.0089
Share-Based Payment Arrangement, Option [Member]
Weighted average exercise price (in dollars per share)	$ 0.99	$ 3.91
Share-Based Payment Arrangement, Option [Member] | Measurement Input, Price Volatility [Member]
Measurement Input	0	1.0342
Share-Based Payment Arrangement, Option [Member] | Measurement Input, Expected Term [Member]
Measurement Input	0	2.75
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]
Risk free interest rate	2.56%	0.16%
Volatility	101.23%	100.72%
Expected term (in years) (Year)	2 years 6 months	2 years 6 months
Measurement Input	0
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]
Risk free interest rate	2.97%	0.85%
Volatility	103.98%	105.43%
Expected term (in years) (Year)	5 years 6 months	5 years 6 months
Measurement Input		3.74

Note 9 - Stock-Based Compensa_3

Note 9 - Stock-Based Compensation (Details Textual) - USD ($)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Dec. 28, 2021

Jun. 08, 2021

Apr. 09, 2021

Apr. 19, 2019

Aug. 31, 2022

Jun. 30, 2022

May 31, 2022

Apr. 30, 2022

Mar. 31, 2022

Jan. 31, 2022

Nov. 30, 2021

Oct. 31, 2021

Jun. 30, 2021

Apr. 30, 2021

Mar. 31, 2021

Jan. 31, 2021

Oct. 31, 2020

Jul. 31, 2020

Sep. 30, 2022

Jun. 30, 2022

Mar. 31, 2022

Dec. 31, 2021

Sep. 30, 2021

Jun. 30, 2021

Mar. 31, 2021

Dec. 31, 2020

Dec. 31, 2021

Sep. 30, 2022

Sep. 30, 2021

Feb. 28, 2021

Jan. 08, 2021

Jun. 02, 2015

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

466,713

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 25,000

$ 129,960

$ (593,617)

$ 328,514

$ 508,754

$ 479,899

$ 590,292

$ 1,181,828

$ 15,279

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)

1,260,000

279,547

Prepaid Expense in Conjunction With the Issuances of Shares [Member]

Prepaid Expense

$ 80,500

$ 143,600

$ 155,200

Share-Based Payment Arrangement, Employee [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

5,000

30,000

120,000

5,000

167,500

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 3,350

$ 29,250

$ 494,125

Share-Based Payment Arrangement, Expense

$ 0

Former Executive Officer [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

400,000

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 172,000

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)

500,000

Stock Issued During Period, Value, Restricted Stock Award, Forfeitures

$ 880,428

Former Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

50%

Executive Officer [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

4 months

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

125,000

25,000

25,000

750,000

50,000

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 100,000

Board of Directors [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

20,000

27,000

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 16,360

$ 118,800

Board of Directors [Member] | Share-Based Payment Arrangement, Tranche One [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

25%

Board of Directors [Member] | Share-Based Payment Arrangement, Tranche Two [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

25%

Board of Directors [Member] | Share-Based Payment Arrangement, Tranche Three [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

25%

Board of Directors [Member] | Share-Based Payment Arrangement, Tranche Four [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

25%

Professional Athlete [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

180,000

Stock Issued During Period, Shares, Issued for Services (in shares)

320,000

320,000

180,000

Stock Issued During Period, Value, Issued for Services

$ 336,000

$ 1,400,000

$ 800,000

$ 800,000

Share-Based Payment Arrangement, Expense

850,000

Professional Athlete [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]

Prepaid Expense

$ 649,800

$ 649,800

Consultant [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)

5 years

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

25,000

Share-Based Payment Arrangement, Expense

$ 131,300

Professional Athlete [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

40,000

40,000

180,000

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 800,000

Director [Member]

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)

5,000

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 2,854

Share-Based Payment Arrangement, Option [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

12 months

Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount

$ 301,126

$ 301,126

Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)

2 years 3 months 18 days

Share-Based Payment Arrangement, Option [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]

Prepaid Expense

$ 125,250

125,250

Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)

10 years

Share-Based Payment Arrangement, Expense

$ 79,500

Share-Based Payment Arrangement, Option [Member] | Former Executive Officer [Member]

Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total

$ 555,286

555,286

Shares Issued, Value, Share-Based Payment Arrangement, Forfeited

$ 604,714

Share-Based Payment Arrangement, Option [Member] | Executive Officer [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)

5 years

Share-Based Payment Arrangement, Option [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

1 year

Share-Based Payment Arrangement, Option [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

2 years

Share-Based Payment Arrangement, Option [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

3 years

Share-Based Payment Arrangement, Option [Member] | Board of Directors [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)

5 years

5 years

Share-Based Payment Arrangement, Option [Member] | Board of Directors [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]

Prepaid Expense

$ 57,000

$ 395,850

$ 57,000

395,850

Restricted Stock [Member]

Share-Based Payment Arrangement, Expense

$ 373,610

$ 1,626,613

Restricted Stock [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]

Prepaid Expense

$ 80,500

$ 80,500

Restricted Stock [Member] | Former Executive Officer [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures (in shares)

500,000

Restricted Stock [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

1 year

Restricted Stock [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

2 years

Restricted Stock [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

3 years

Restricted Stock [Member] | Board of Directors [Member]

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 2,520,000

Stock Issued During Period, Value, Issued for Services

$ 118,800

Restricted Stock [Member] | Board of Directors [Member] | Vesting June, 30, 2021 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

25%

Restricted Stock [Member] | Board of Directors [Member] | Vesting September, 30, 2021 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

25%

Restricted Stock [Member] | Professional Athlete [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]

Prepaid Expense and Other Assets

$ 649,800

$ 649,800

Restricted Stock [Member] | Professional Athlete [Member] | Prepaid Expense in Conjunction With the Issuances of Shares [Member]

Prepaid Expense

$ 143,600

Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)

120,000

Restricted Stock Units (RSUs) [Member] | Former Executive Officer [Member]

Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total

$ 799,572

$ 799,572

Maximum [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)

10 years

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

3 years

Minimum [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)

5 years

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

1 year

Minimum [Member] | Restricted Stock [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)

1 year

The 2015 Plan [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)

1,175,000

Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Percentage

1%

Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)

2,000,000

The 2015 Plan [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Shares (in shares)

100,000

The 2021 Plan [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)

5,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Percentage

1%

The 2021 Plan [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Shares (in shares)

250,000

Equity Compensation Plan [Member] | Consultant [Member]

Stock Issued During Period, Shares, Issued for Services (in shares)

100,000

Stock Issued During Period, Value, Issued for Services

$ 41,000

Note 9 - Stock Based Compensati

Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details) - $ / shares	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Outstanding (in shares)	2,702,500		1,750,000
Outstanding, weighted average exercise price (in dollars per share)	$ 4.42		$ 4.68
Granted (in shares)	1,060,000	1,380,000
Granted, weighted average exercise price (in dollars per share)	$ 0.97	$ 3.91
Exercised (in shares)	0	(147,953)
Exercised, weighted average exercise price (in dollars per share)	$ 0	$ 2.60
Forfeited (in shares)	(1,260,000)	(279,547)
Forfeited, weighted average exercise price (in dollars per share)	$ 3.63	$ 4.47
Outstanding, weighted average remaining contractual term (Year)	4 years 6 months 18 days		5 years 1 month 17 days
Outstanding (in shares)	2,502,500	2,702,500
Outstanding, weighted average exercise price (in dollars per share)	$ 3.36	$ 4.42
Outstanding, weighted average remaining contractual term (Year)	4 years 6 months 18 days		5 years 1 month 17 days
Exercisable (in shares)	1,549,167
Exercisable, weighted average exercise price (in dollars per share)	$ 4.13
Exercisable at September 30, 2022 (Year)	4 years 8 months 8 days

Note 10 - Warrants - Schedule o

Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details) - $ / shares	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Outstanding, warrant, contractual term (Year)	2 years 3 months 18 days
Granted, warrants (in shares)	0	293,984
Granted, warrant, weighted average exercise price (in dollars per share)	$ 0	$ 3.75
Exercised, warrants (in shares)	0	(323,444)
Exercised, warrant, weighted average exercise price (in dollars per share)	$ 0	$ 1.25
Forfeited, warrants (in shares)	(70,500)	(224,307)
Forfeited, warrant, weighted average exercise price (in dollars per share)	$ 4	$ 5.39
Outstanding, warrants (in shares)	589,917
Outstanding, warrant, weighted average exercise price (in dollars per share)	$ 4.68
Class of warrants, exercisable (in shares)	589,917
Exercisable, weighted average exercise price (in dollars per share)	$ 4.68
Warrants to Purchase Common Stock [Member]
Outstanding, warrants (in shares)	660,417	914,184
Outstanding, warrant, weighted average exercise price (in dollars per share)	$ 4.60	$ 3.88
Outstanding, warrant, contractual term (Year)		3 years 18 days	3 years 2 months 23 days
Outstanding, warrants (in shares)		660,417
Outstanding, warrant, weighted average exercise price (in dollars per share)		$ 4.60
Class of warrants, exercisable (in shares)	589,917
Exercisable, weighted average exercise price (in dollars per share)	$ 4.68

Note 10 - Warrants - Summary of

Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)	Sep. 30, 2022 $ / shares shares
Class of warrants, exercisable (in shares) | shares	589,917
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 4.68
Warrants Expiring October 2022 [Member]
Class of warrants, exercisable (in shares) | shares	100,000
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 7.50
Warrants Expiring September 2023 [Member]
Class of warrants, exercisable (in shares) | shares	51,429
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 4.375
Warrants Expiring May 2024 [Member]
Class of warrants, exercisable (in shares) | shares	60,000
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 7.50
Warrants Expiring October 2024 [Member]
Class of warrants, exercisable (in shares) | shares	47,822
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 3.9125
Warrants Expiring January 2025 [Member]
Class of warrants, exercisable (in shares) | shares	36,682
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 1.25
Warrants Expiring December 2025 [Member]
Class of warrants, exercisable (in shares) | shares	150,502
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 3.74
Warrants Expiring June 2026 [Member]
Class of warrants, exercisable (in shares) | shares	143,482
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 3.75

Note 11 - Commitments and Con_2

Note 11 - Commitments and Contingencies (Details Textual) - USD ($)	1 Months Ended		3 Months Ended	6 Months Ended					12 Months Ended		30 Months Ended
	Jan. 31, 2022	Jul. 31, 2020	Mar. 31, 2021	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2022	Apr. 30, 2022	May 31, 2019
Professional Athlete [Member]
Stock Issued During Period, Value, Issued for Services	$ 336,000	$ 1,400,000				$ 800,000				$ 800,000
Payments for Endorsements					$ 85,000	$ 75,000	$ 50,000	$ 40,000
Stock Issued During Period, Shares, Issued for Services (in shares)	320,000		320,000			180,000
Other Expenses									$ 971,554	577,034
Share-Based Payment Arrangement, Expense										$ 850,000
Professional Athlete [Member] | Forecast [Member]
Stock Issued During Period, Value, Issued for Services				$ 667,000							$ 2,867,000
Payments for Endorsements				$ 100,000
Professional Athlete Endorsement Agreement [Member]
Other Commitment, Total												$ 1,500,000	$ 4,900,000
Other Commitment, to be Paid, Remainder of Fiscal Year													400,000
Other Commitment, to be Paid, Year One													800,000
Other Commitment, to be Paid, Year Two													1,800,000
Other Commitment, to be Paid, Year Three													$ 1,900,000

Note 12 - Note Payable (Details

Note 12 - Note Payable (Details Textual) - USD ($)	1 Months Ended
	Jan. 31, 2020	Sep. 30, 2022	Jul. 31, 2019
Loan Arrangement for Line of Equipment, One [Member]
Debt Instrument, Face Amount			$ 249,100
Long-Term Debt, Total		$ 0
Loan Arrangement for Line of Equipment, Two [Member]
Debt Instrument, Face Amount	$ 35,660
Long-Term Debt, Total	$ 3,000
Loan Arrangement for Line of Equipment, Two [Member] | Notes Payable [Member]
Debt Instrument, Term (Month)	48 months
Debt Instrument, Interest Rate, Stated Percentage	6.20%
Debt Instrument, Periodic Payment, Total	$ 841

Note 13 - Paycheck Protection_2

Note 13 - Paycheck Protection Program Loan (Details Textual)	Apr. 27, 2020 USD ($)
Paycheck Protection Program Loan [Member]
Proceeds from Short-Term Debt, Total	$ 1,456,100

Note 14 - Leases (Details Textu

Note 14 - Leases (Details Textual)	Sep. 30, 2022	Sep. 30, 2021
Operating Lease, Weighted Average Remaining Lease Term (Year)	3 years 10 months 28 days
Operating Lease, Weighted Average Discount Rate, Percent		4.66%

Note 14 - Leases - Operating Le

Note 14 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)	12 Months Ended
	Sep. 30, 2022 USD ($)
Total Operating Lease Costs	$ 1,391,856
Cash paid for amounts included in the measnurement of operating lease liabilities	$ 1,405,887

Note 14 - Leases - Future Minim

Note 14 - Leases - Future Minimum Aggregate Lease Payments (Details) - USD ($)	Sep. 30, 2022	Sep. 30, 2021
2023	$ 1,380,204	$ 1,405,887
2024	1,421,610	1,380,204
2025	1,159,949	1,421,610
Thereafter	1,372,862
Total future lease payments	5,334,625	6,740,512
Less interest	(475,567)	(730,304)
Total lease liabilities	4,859,058	6,010,208
2022	1,380,204	1,405,887
2023	1,421,610	1,380,204
2024	$ 1,159,949	1,421,610
2025		1,159,949
Thereafter		$ 1,372,862

Note 15 - Loss Per Share (Detai

Note 15 - Loss Per Share (Details Textual)	12 Months Ended
	Sep. 30, 2022 shares
Options, RSUs and Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	3,335,750
Series A Cumulative Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	8,335,000

Note 15 - Loss Per Share - Basi

Note 15 - Loss Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($)	3 Months Ended								12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2022	Sep. 30, 2021
Net income (loss)	$ (14,631,432)	$ (31,634,143)	$ (4,657,215)	$ (19,160,904)		$ 1,537,288	$ (12,510,474)	$ (9,395,621)	$ (70,083,693)	$ (23,394,889)
Preferred dividends paid									4,002,005	2,554,609
Net income (loss) continuing operations adjusted for preferred dividend									(74,085,698)	(25,949,498)
Net income (loss) attributable to cbdMD Inc. common shareholders									(74,085,698)	(25,949,498)
Net income (loss)									(74,085,698)	(25,949,498)
Net income (loss)									$ (74,085,698)	$ (25,949,498)
Shares used in computing basic earnings per share (in shares)									59,750,301	54,938,128
Options (in shares)									0	0
Warrants (in shares)									0	0
Convertible preferred shares (in shares)									0	0
Shares used in computing diluted earnings per share (in shares)									59,750,301	54,938,128
Continued operations (in dollars per share)									$ (1.24)	$ (0.47)
Discontinued operations (in dollars per share)									0	0
Basic earnings per share (in dollars per share)									(1.24)	(0.47)
Continued operations (in dollars per share)									(1.24)	(0.47)
Discontinued operations (in dollars per share)									0	0
Diluted earnings per share (in dollars per share)									$ (1.24)	$ (0.47)

Note 16 - Income Taxes (Details

Note 16 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 20, 2018	Sep. 30, 2018
Operating Loss Carryforwards, Valuation Allowance	$ 57,700,000	$ 11,400,000		$ 2,100,000
Deferred Tax Asset And Related Valuation Allowance		2,700,000		$ 500,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	4,758,000	3,351,000
Deferred Tax Assets, Net, Total	$ 11,688,000	$ 6,930,000	$ 4,600,000

Note 16 - Income Taxes - Compon

Note 16 - Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Federal, current	$ 0	$ 0
State, current	0	0
Total current	0	0
Federal, deferred	0	(895,000)
State, deferred	0	0
Total deferred	0	(895,000)
Total provision	$ 0	$ (895,000)

Note 16 - Income Taxes - Reconc

Note 16 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Federal statutory income tax rate	21%	21%
State income taxes, net of federal benefit	0.40%	0.80%
Permanent differences	(17.10%)	1.50%
Contingent derivative expense	2.50%	(5.80%)
Limitation on net operating losses	0%	0%
Change in valuation allowance	(6.80%)	(13.80%)
Benefit from (provision for) income taxes	0%	3.70%

Note 16 - Income Taxes - Signif

Note 16 - Income Taxes - Significant Components of Deferred Income Taxes (Details) - USD ($)	Sep. 30, 2022	Sep. 30, 2021	Dec. 20, 2018
Net operating loss carryforwards	$ 12,909,000	$ 9,160,000
ROU - Liability	1,087,000	1,342,000
Capital loss carryforward	702,000	716,000
Allowance for doubtful accounts	8,000	1,000
Stock compensation	833,000	1,107,000
Investments	452,000	444,000
Accrued expenses	214,000	165,000
Fixed Assets	40,000	0
Inventory reserve	35,000	16,000
Capitalized expenses	48,000	52,000
Charitable contributions	45,000	43,000
Total deferred tax assets	16,373,000	13,046,000
Prepaid Expenses	(257,000)	(219,000)
ROU - Assets	(1,002,000)	(1,254,000)
Intangibles	(3,426,000)	(4,481,000)
Fixed assets	0	(162,000)
Total deferred tax liabilities	(4,685,000)	(6,116,000)
Net deferred tax assets	11,688,000	6,930,000	$ 4,600,000
Valuation allowance	(11,688,000)	(6,930,000)
Net deferred tax liability	$ 0	$ 0

Note 17 - Acquisitions (Details

Note 17 - Acquisitions (Details Textual) - USD ($)		1 Months Ended
	Jul. 22, 2021	Jul. 22, 2021	Sep. 30, 2022	Sep. 30, 2021
Asset Acquisition, Consideration Transferred, Total	$ 2,000,000
Stock Issued During Period, Shares, Acquisitions (in shares)	600,000
Escrow Deposit	$ 200,000	$ 200,000
Common Stock, Shares, Issued (in shares)	300,000	300,000	60,665,595	57,783,340
Common Stock, Shares Subscribed but Unissued (in shares)	100,000	100,000
Common Stock, Capital Shares Reserved for Future Issuance (in shares)	200,000	200,000
Lock Up Agreement Period (Day)		180 days
Stock Issued During Period, Shares, New Issues (in shares)		300,000
Stock Issued During Period, Shares, Other (in shares)		100,000
Stock Issued During Period, Value, Other		$ 1,064,000

Note 17 - Acquisitions - Schedu

Note 17 - Acquisitions - Schedule of Intangible Assets and Goodwill (Details)	Jul. 22, 2022 USD ($)
Consideration	$ 3,552,529
Undeposited Funds	18,155
Inventory	79,895
Inventory - Prepaid Shipping	31,094
Proerpty and equipment, net	5,000
Intangible Assets	3,418,383
Total assets aquired	$ 3,552,529